Annual Meeting Abstract Permissions & Reprints

The names, insignias, logos and acronyms of the ACR, the ARP, and the Rheumatology Research Foundation are proprietary marks. Use of the names in any fashion, by any entity, for any purpose, is prohibited without the express written permission of the American College of Rheumatology.

Copyright law covers all annual meeting abstracts published by the American College of Rheumatology. All rights reserved. No abstracts may be reproduced in any form or by any means without the prior permission of the publisher, except as permitted under section 107 and 108 of the 1976 United States Copyright Act.

For the purposes of this statement, the term “ACR Abstracts” refers to all annual meeting abstracts as published in Arthritis & Rheumatology and posted online, including the abstracts accepted for presentation during ARP sessions and the late-breaking category.

For the purposes of this statement, the term “ACR Posters” refers to the accepted abstract POSTER PRESENTATIONS as presented in the poster hall during the annual meeting. This does not include abstract text published in the online supplement of Arthritis & Rheumatology. All ACR Posters are the property of the ACR or the presenting author and cannot be reproduced or distributed without written permission from the ACR and the presenting author.

For the purposes of this statement, the term “reproduce” includes all forms of reproduction including, but not limited to, print, electronic, and photographed formats.

For the purposes of this statement, the term “presenting author” refers to the author who is designated as the individual who will present the work during the ACR's annual meeting, as identified through the abstract submission process.

Approval Process for ACR Abstracts

• Excerpts or the entirety of ACR Abstracts may not be reproduced without the prior written permission of the publisher.
• Permission requests for abstract content and other permission inquiries should be addressed to:

Permissions Department
c/o John Wiley & Sons, Inc.
111 River Street
Hoboken, NJ 07030
Fax: 201-748-6008
wiley.com/go/permissions

• Commercial entities seeking permission to reprint must obtain all materials from the author and/or publisher, John Wiley & Sons, Inc. The ACR cannot provide any materials.

Approval Process for ACR Posters

• Reprint requests for the actual poster abstract text published in the Arthritis & Rheumatology supplement are considered ACR Abstracts and must be submitted to Wiley (see approval process above).
• Requests to reproduce individual ACR Posters, figures from ACR Posters, or booklets of poster presentations (e.g., two or more) must be submitted via email to abstractreprints@rheumatology.org.
• Poster reproduction requests must include the following:

– Abstract ID Number
– Abstract Title
– Presenting Author’s Name
– A copy of Presenting Author’s written approval (Please Note: An email approval from Presenting Author is acceptable)

Reproducing ACR Abstracts and Posters for Dissemination Prior to Annual Meeting

• Requests to reproduce abstracts for dissemination prior to the annual meeting will not be approved.
• Per the ACR Embargo Policy, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract online.
• Permission to issue a press release does not require ACR approval. However, it must comply with the ACR Embargo Policy; violation of this policy may result in the abstract being withdrawn from the meeting or other measures deemed appropriate.
• For more information regarding press releases, please contact the ACR Public Relations Department at pr@rheumatology.org.

Reproducing ACR Abstracts and Posters for Dissemination During Annual Meeting

Following approval (see approval process above), an exhibiting organization may:

• Disseminate copies of individual ACR Abstracts from its exhibit space. Booklets of abstracts (e.g., two or more) may not be produced.
• Disseminate information summaries (title/date/time/poster number) of ACR Abstracts from its exhibit space.
• Summaries may not reference company or product names. Requests for approval must be submitted in writing to abstractreprints@rheumatology.org.
• Presenting authors may disseminate individual copies of their ACR Poster during their assigned poster presentation time.
• Dissemination must be limited to the area directly in front of their assigned poster space and may not interfere with other poster presentations.
• An electronic copy of the poster may be provided via a QR code generated by the presenter and included on the poster

Reproducing ACR Abstracts and Posters for Dissemination After Annual Meeting

ACR Abstracts

Following approval from Wiley (see approval process above), the ACR permits ACR Abstracts (i.e., all abstract content published in the online supplement) to be reprinted and disseminated following the annual meeting.

• Abstracts and booklets of abstracts (e.g., two or more) must include the following statement on the front of the abstract/booklet:

Abstract(s) reprinted from ACR Convergence held [insert meeting dates]. The American College of Rheumatology does not guarantee, warrant, or endorse any commercial products or services. Reprinted by (insert name of supporting company).

• Booklets cannot contain corporate or product logos or any advertisements. No exceptions.

ACR Posters

Following approval from the presenting author and ACR (see approval process above), copies of actual ACR poster presentations (i.e., images of the poster presentation hung in the poster hall) may be reproduced.

• Reprint requests for the actual poster abstract text published in the Arthritis & Rheumatology supplement are considered ACR Abstracts and must submitted to Wiley (see approval process above).

• IMPORTANT: The ACR does not retain and cannot provide poster presentation images.
• The following statement must be listed under each poster reprint:

Reprinted from ACR Convergence held [insert meeting dates]. The American College of Rheumatology does not guarantee, warrant, or endorse any commercial products or services. Reprinted by [insert name of supporting company].

Use of the ACR Disclosure Key

It is suggested when referencing disclosures in the reprints, that the ACR’s disclosure key be added to provide adequate context for abstracts:

1. Advisor or review panel member
2. Consultant
3. Employee
4. Officer or Board Member
5. Grant/research support
6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
7. Independent contractor
8. Executive role and/or ownership interest
9. Royalties and/or patient beneficiary
10. Intellectual property/patents
11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
12. Private investigator
13. Expert witness
14. Equity interest
15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

Use of the ACR Scientific Program Content

• Information displayed or presented at all sessions during the annual meeting is the property of the ACR or the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced or distributed without the prior written permission of the ACR and the presenter. See Photography and Video Recording Policy.
• Any use of the program content, which includes but is not limited to oral presentations, audiovisual materials used by speakers and program handouts, without the written consent of the ACR is prohibited.
• This policy applies before, during, and after the meeting.
• The ACR will enforce its intellectual property rights and penalize those who infringe upon it.